Orpea S.A. (ORRRY) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Orpea S.A. (ORRRY) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 45/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026Orpea S.A. (ORRRY) Resumen de Asistencia Médica y Tuberías
Orpea S.A., a global healthcare provider based in France, operates nursing homes, assisted-living facilities, and rehabilitation hospitals. With a focus on elderly care and rehabilitation services across multiple countries, Orpea faces challenges in a competitive and regulated healthcare landscape while navigating financial performance issues reflected in its negative profit margin.
Tesis de Inversión
Orpea S.A. presents a complex investment case. The company's global presence in the growing elderly care market offers long-term potential, driven by demographic trends and increasing demand for specialized care facilities. However, Orpea's negative profit margin of -5.1% and negative P/E ratio of -4.62 raise concerns about its financial performance. The company's beta of 0.76 suggests lower volatility compared to the market. Successful execution of its restructuring plans and improved operational efficiency are critical for restoring profitability and investor confidence. Monitoring key metrics such as occupancy rates, cost management, and regulatory compliance is essential for assessing Orpea's investment viability.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.37 billion reflects investor valuation of Orpea S.A.
- Negative P/E ratio of -4.62 indicates current unprofitability.
- Profit margin of -5.1% highlights challenges in achieving profitability.
- Gross margin of 2.2% suggests limited pricing power or high cost of services.
- Beta of 0.76 indicates lower volatility compared to the overall market.
Competidores y Pares
Fortalezas
- Global presence and diversified operations.
- Comprehensive range of healthcare services.
- Experienced management team.
- Established relationships with payers.
Debilidades
- Negative profit margin.
- High debt levels.
- Exposure to regulatory risks.
- Reputational risks.
Catalizadores
- Ongoing: Implementation of restructuring plans to improve financial performance.
- Ongoing: Expansion of specialized care services to attract a higher paying customer base.
- Upcoming: Potential acquisitions of smaller care facilities to expand geographic footprint.
- Ongoing: Technological innovation to improve efficiency and quality of services.
- Ongoing: Expansion of home care services to cater to the growing demand for in-home care.
Riesgos
- Ongoing: Negative profit margin and high debt levels.
- Potential: Changes in government regulations and reimbursement models.
- Potential: Increasing competition from other healthcare providers.
- Potential: Economic downturns affecting demand for services.
- Ongoing: Reputational risks associated with quality of care and ethical practices.
Oportunidades de crecimiento
- Expansion into emerging markets: Orpea can capitalize on the growing demand for elderly care services in emerging markets such as Brazil, Russia, and China. These markets offer significant growth potential due to their large populations and increasing healthcare spending. Successful entry and adaptation to local regulations and cultural nuances are crucial for success. This expansion could contribute significantly to revenue growth over the next 5-10 years.
- Development of specialized care services: Orpea can enhance its service offerings by developing specialized care programs for specific conditions such as dementia, Alzheimer's disease, and Parkinson's disease. These specialized programs can attract a higher paying customer base and differentiate Orpea from its competitors. The market for specialized care services is expected to grow significantly in the coming years, driven by the increasing prevalence of these conditions. Timeline for implementation is 2-3 years.
- Strategic acquisitions: Orpea can pursue strategic acquisitions of smaller care facilities and regional operators to expand its geographic footprint and market share. Acquisitions can provide access to new markets, technologies, and talent. Careful due diligence and integration are essential for realizing the full benefits of acquisitions. This strategy could yield significant growth within 3-5 years.
- Technological innovation: Orpea can invest in technological innovation to improve the efficiency and quality of its services. This includes implementing electronic health records, telemedicine solutions, and remote monitoring devices. Technology can help to reduce costs, improve patient outcomes, and enhance the overall care experience. Implementation of these technologies can begin immediately and show results within 1-2 years.
- Enhanced home care services: Orpea can expand its home care services to cater to the growing demand for in-home care. Home care services offer a more affordable and convenient alternative to facility-based care for many elderly individuals. Orpea can leverage its existing infrastructure and expertise to provide high-quality home care services. This expansion can be implemented within the next year and contribute to revenue growth over the long term.
Oportunidades
- Expansion into emerging markets.
- Development of specialized care services.
- Strategic acquisitions.
- Technological innovation.
Amenazas
- Increasing competition.
- Changes in government regulations.
- Economic downturns.
- Labor shortages.
Ventajas competitivas
- Established brand reputation in the healthcare industry.
- Extensive network of facilities across multiple countries.
- Specialized expertise in elderly care and rehabilitation services.
- Long-term relationships with insurance companies and government programs.
Acerca de ORRRY
Founded in 1989, Orpea S.A. has grown into a multinational healthcare provider specializing in long-term care and rehabilitation services. Headquartered in Puteaux, France, the company operates a network of nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals across Europe, Latin America, and Asia. Orpea's facilities provide a comprehensive range of services, including accommodation, meals, personalized support, and specialized medical care for elderly and dependent individuals. The company's post-acute and rehabilitation hospitals offer services for various conditions, including geriatrics, musculoskeletal, nervous system, and cardiovascular issues. Its psychiatric hospitals cater to patients with mood disorders, anxiety disorders, and other mental health conditions. In addition to facility-based care, Orpea also offers home care services, including housekeeping, daily life assistance, and movement assistance. With operations in over 20 countries, Orpea has established a significant presence in the global healthcare market, employing approximately 76,000 people.
Qué hacen
- Operates nursing homes providing personalized support services.
- Manages assisted-living facilities for elderly individuals.
- Runs post-acute and rehabilitation hospitals for various medical conditions.
- Offers psychiatric hospital services for patients with mental health disorders.
- Provides home care services including housekeeping and daily life assistance.
- Offers accommodation, meals, and laundry services in its facilities.
- Organizes daily events, entertainment, and therapeutic workshops for residents.
Modelo de Negocio
- Generates revenue from accommodation and care services provided in its facilities.
- Receives payments from residents, insurance companies, and government programs.
- Offers a range of services including medical care, rehabilitation, and assisted living.
- Expands its network through acquisitions and development of new facilities.
Contexto de la Industria
Orpea S.A. operates within the medical care facilities industry, which is experiencing growth due to the aging global population and increasing demand for long-term care services. The industry is characterized by a mix of public and private providers, with varying levels of regulation and reimbursement models. Key competitors include BTMD (BioTelemetry Inc.), CSSPF (Care Solutions Holding SA), DFHL (Dahongli Investment Holding Co Ltd), GUERF (Guerbet SA), and HYBT (Hybertone Corporation). Orpea's success depends on its ability to provide high-quality care, manage costs effectively, and navigate the complex regulatory landscape in each of its operating countries. The industry is also facing increasing scrutiny regarding quality of care and ethical practices.
Clientes Clave
- Elderly individuals requiring long-term care.
- Patients needing post-acute and rehabilitation services.
- Individuals with mental health disorders seeking psychiatric care.
- Families seeking care solutions for their loved ones.
Finanzas
Gráfico e información
Precio de la acción de Orpea S.A. (ORRRY): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para ORRRY.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ORRRY.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para ORRRY.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ORRRY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Liderazgo: Laurent Guillot
CEO
Laurent Guillot is the CEO of Orpea S.A. His background includes extensive experience in managing large organizations and driving strategic growth. Prior to joining Orpea, he held leadership positions in various multinational companies, focusing on operational efficiency and business development. He is known for his expertise in navigating complex regulatory environments and implementing successful turnaround strategies. His educational background includes advanced degrees in business administration and engineering.
Historial: Since assuming the role of CEO, Laurent Guillot has focused on restructuring Orpea's operations and restoring investor confidence. Key initiatives include implementing cost-saving measures, improving quality of care, and strengthening relationships with regulatory authorities. He has also overseen the development of new strategic partnerships and the expansion of Orpea's services in key markets. His leadership is aimed at driving sustainable growth and enhancing shareholder value.
Información de ADR de Orpea S.A. No patrocinado
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. ORRRY, as an ADR, allows U.S. investors to invest in Orpea S.A. without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars, simplifying trading and reporting for U.S. investors. The underlying shares are held by a custodian bank in the home country, France.
- Ticker del mercado local: Euronext Paris, France
- Nivel de ADR: 1
- Ratio de ADR: 1:1
- Ticker del mercado local: ORRR
Información del mercado OTC de ORRRY
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited liquidity, price volatility, and lack of regulatory oversight compared to exchange-listed stocks. Investors should exercise caution and conduct thorough due diligence before investing in ORRRY.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure.
- Potential for price manipulation.
- Higher risk of fraud.
- Lower liquidity.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's risk factors.
- Understand the OTC market and its associated risks.
- Consult with a qualified financial advisor.
- Positive news coverage and media mentions.
- Partnerships with reputable organizations.
- Active engagement with investors and stakeholders.
- Clear and transparent communication.
- Compliance with applicable laws and regulations.
ORRRY Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar ORRRY?
Orpea S.A. (ORRRY) actualmente tiene una puntuación IA de 45/100, indicando puntuación baja. Fortaleza clave: Global presence and diversified operations.. Riesgo principal a monitorear: Ongoing: Negative profit margin and high debt levels.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ORRRY?
ORRRY actualmente puntúa 45/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ORRRY?
Los precios de ORRRY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ORRRY?
La cobertura de analistas para ORRRY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ORRRY?
Las categorías de riesgo para ORRRY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Negative profit margin and high debt levels.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ORRRY?
La relación P/E para ORRRY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ORRRY sobrevalorada o infravalorada?
Determinar si Orpea S.A. (ORRRY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ORRRY?
Orpea S.A. (ORRRY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data may be outdated or incomplete.
- AI analysis is pending and may provide additional insights.
- OTC market investments carry higher risks.